Chemoinformaics analysis of 13-nor-7,8-Epoxy-eremophil-1(10)-en-11-one
| Molecular Weight | 220.312 | nRot | 1 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 14 |
| Exact Molecular Weight | 220.146 | nRing | 3 |
| Solubility: LogS | -3.708 | nHRing | 1 |
| Solubility: LogP | 2.652 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 38.3199 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.502 |
| Synth | 4.635 |
| Natural Product Likeliness | 2.636 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.555 |
| MDCK | 0.0000249 |
| BBB | 0.573 |
| PPB | 0.860197 |
| VDSS | 1.971 |
| FU | 0.164058 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.89 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.941 |
| CYP2c9-inh | 0.046 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.595 |
| CYP3a4-inh | 0.313 |
| CYP3a4-sub | 0.538 |
| CL | 16.567 |
| T12 | 0.447 |
| hERG | 0.003 |
| Ames | 0.061 |
| ROA | 0.23 |
| SkinSen | 0.074 |
| Carcinogencity | 0.938 |
| EI | 0.605 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.753 |
| Antiviral | Yes |
| Prediction | 0.868835 |